The ever-increasing presence of a variety of dermatologic conditions across the lifespan, including in neonates, children, and adolescents, continues to be a major challenge for healthcare providers in the United States. Current estimates predict that up to 30% of primary care visits in the US involve a skin- related issue, with some of the most common conditions including atopic dermatitis, seborrheic dermatitis, contact dermatitis, acne, neonatal rashes, and sunburn among others (Castelo-Soccio 2017). Acne is one of the most common skin conditions, affecting up to 50 million individuals annually; approximately 85% of people between the ages of 12-24 experience at least an episode of acne in their lifetime, with more than 5.1 million individuals, mostly children and young adults, seeking acne care annually (AAD). One in 10 people develop atopic dermatitis in their lifetime, and it is estimated that 60% of people with this condition develop it in their first year of life, and 90% develop it before the age of 5 (AAD). In 2013, the combined cost of acne and atopic dermatitis exceeded $1.5 billion, posing a significant burden to the US healthcare system. Worldwide, over 125 million individuals have psoriasis –8 million of which are currently living with the disease in the United States, alone (Psoriasis.org). Although psoriasis onset peaks at ages 20-30 and 50-60, one third of individuals develop the disease during childhood (Paller 2018, Pinson 2016). Moreover, infantile hemangiomas, warts, molluscum, vitiligo, acne and hyperhidrosis in the pediatric population also pose a significant burden. This sampling of sobering statistics points to a rapidly growing need for medical education focused on all aspects of pediatric dermatology care.
Despite these demands, there is a shortage of pediatric dermatologists in the United States, and more often the burden of care falls to the dermatologists, pediatricians, and family care physicians (Castelo-Soccio 2017). Despite receiving inadequate training, pediatricians are often at the front line of assessing and treating dermatologic conditions (Castelo-Soccio 2017), and often are in fear of missing critical diagnoses, which are difficult to make considering the overlapping symptoms of these conditions (Stein 2015). According to Sarah L. Stein, MD, Associate Professor of Pediatrics at the University of Chicago, “textbooks of dermatology are brimming with obscure and esoteric diagnoses, providing an intimidating breadth of knowledge even for those of us immersed in the study of the skin” (Stein 2015). Thus, education for these clinicians remains imperative to meet the demands of these increasingly complex disease states in the pediatric population and to improve outcomes (Castelo-Soccio 2017). Given the burgeoning field of clinical dermatology, this workshop will provide a unique opportunity to pediatricians to get additional education on the diagnosis and treatment of common dermatologic conditions they see in everyday practice.
The Masters of Pediatric Dermatology at the ICAAP: Expert Guidance for Diagnosis, Management, and Referral of Childhood Skin Conditions is an expert-led pre-conference workshop preceding the Illinois Chapter of the American Academy of Pediatrics 2022 annual meeting. Educational training for pediatricians remains imperative to meet the growing demands of increasingly complex dermatologic disease states in the pediatric patient population. Led by program chair Dr. Lawrence Schachner, leaders in the field of pediatric dermatology will provide a comprehensive update to improve pediatricians’ knowledge and competence in diagnosing, managing, and referring various dermatologic conditions. This workshop will include lectures and case-based discussions of dermatologic conditions seen in pediatric patients from infants to adolescents, including nuances to diagnosis and treatment for diverse skin types.
- Discuss strategies for accurate and timely diagnosis and treatment of infantile hemangioma
- Interpret the clinical safety and efficacy of current and emerging therapies for atopic dermatitis
- Review expert recommendations for treatment of acne across pediatric age groups
- Select appropriate therapies for safe and effective management of hyperhidrosis in pediatric patients
- Summarize current and emerging treatment strategies for molluscum and warts in pediatric patients
- Identify emerging agents being developed for pediatric patients with vitiligo
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and LivDerm. Global is accredited by the ACCME to provide continuing medical education for physicians.
* This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.
Global Education Group designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Education Group designates this continuing education activity for 3.0 contact hour(s) (3.0 CEUs)
Universal Activity Number – 0530-9999-21-414-L01-P
This is a knowledge based activity.
This educational activity for 3.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
For information about the accreditation of this program, please contact Global at: